Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-023346

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Oct 3, 2017
Accepted (ET)
Oct 3, 2017 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Oct 3, 2017X189,780$7.86A1,227,774D
Common StockF2Oct 3, 2017X78,186$7.86A513,630D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to purchase)$7.86Oct 3, 2017X189,780DNov 21, 2012Nov 21, 2017Common Stock189,7800D
Warrant (right to purchase)$7.86Oct 3, 2017X78,186DNov 21, 2012Nov 21, 2017Common Stock78,1860D

Explanation of responses

Remarks

Form 2 of 2. Because the number of Reporting Persons exceeds the Form 4 limit, additional Reporting Persons are included on another Form 4 filed on the same date.